You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

166 Results
Guidelines and Advice
Status: Current
ID: GL-1-A-2016-2
Oct 2017
Guidelines and Advice
Status: Archived
ID: 18-4
Sep 2017
Guidelines and Advice
Status: Current
ID: GL-END MOTAC 5
Aug 2017
Guidelines and Advice
Status: Current
ID: 15-15
Sep 2017
Guidelines and Advice
Status: Current
Jun 2017
Drug
Other Name(s): Uromitexan® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Nov 2017
Drug
Other Name(s): Faslodex®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jan 2024
Drug
Other Name(s): Oncovin® (multiple brands available)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Nov 2017
Drug
Other Name(s): Tagrisso®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jan 2024
Drug
Other Name(s): Onivyde® (Baxalta Canada)
Quick Link(s):
Drug Monograph, Patient Info Sheet
Sep 2017
Regimen
Cancer Type:
Gastrointestinal, 
Esophagus, 
Gastric / Stomach
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant, Palliative
Drugs Used:
CISplatin,
fluorouracil
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2017
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) - Adjuvant Treatment for Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
DOCEtaxel,
cyclophosphamide,
trastuzumab
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph, Patient Info Sheet (CYCLDOCE)
Jan 2024

Pages